Technical complications of continuous intra-arterial chemotherapy with 5-fluorodeoxyuridine and 5-fluorouracil for colorectal liver metastases

Surgery

Volumn 133, Issue 1, 2003, Pages 40-48

  Heinrich, Stefan ^a,b   Petrowsky, Henrik ^a,b   Schwinnen, Ingo ^a,b   Staib Sebler, Elsbeth ^a,b   Gog, Christiane ^a,b   El Ganainy, Ahmed ^a,b   Gutt, Carsten ^a,b   Müller, Hans Helge ^a,b   Lorenz, Matthias ^a,b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLOXURIDINE; FLUOROURACIL;

ADULT; ARTERY CATHETER; ARTICLE; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; HUMAN; INFECTION; INFUSION PUMP; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SURGICAL TECHNIQUE; THROMBOSIS;

EID: 0037270453     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2003.37     Document Type: Article

References (37)

1. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991;110:13-99.
2. Rougier P, Milan C, Lazorthes F, Fourtainier G, Partensky C, Baumel H, et al. Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Br J Surg 1995;82:1397-400.
3. Davis HL. Chemotherapy of large bowel cancer. Cancer 1982;50:2638-46.
4. Köhne-Wömpner CH., Chemotherapeutic strategies in metastatic colorectal cancer: an overview of current clinical trials. Semin Oncol 1992;19:105-25.
5. Archer SG, Gray BN. Vascularization of small liver metastases. Br J Surg 1989;76:545-8.
6. Ackermann NB. The blood supply of experimental liver metastases: IV, changes in vascularity with increasing tumor growth. Surgery 1974;75:589-69.
7. Kemeny NE. Regional chemotherapy of colorectal cancer. Eur J Cancer 1995;31A:1271-6.
8. Lorenz M, Müller HH for the German Cooperative Group on Liver Metastases (ALM). Randomized, multicenter trial of 5-fluorottracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with non-resectable liver metastases from colorectal carcinoma. J Clin Oncol 2000;18:243-54.
9. Curley SA, Chase JL, Roh MS, Hohn DC. Technical considerations and complications associated with the placement of 180 implantable hepatic arterial infusion devices. Surgery 1993;114:928-35.
10. Fordy C, Burke D, Earlam S, Twort P, Allen-Mersh TG. Treatment interruptions and complications with two continous hepatic artery, floxuridine infusion systems in colorectal liver metastases. Br J Cancer 1995;72:1023-5.
11. Watkins E, Khazei AM, Nahra KS. Surgical basis for arterial infusion chemotherapy of disseminated carcinoma of the liver. Surg Gynecol Obstet 1970;130:581-605.
12. Rayner AA, Kerlan RK, Stagg RJ, Price DC, Hohn DC. Total hepatic arterial perfusion after occlusion of variant lobar vessels: implications for hepatic arterial chemotherapy. Surgery 1986;99:708-14.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. JASA 1958;53:457-62.
14. Meta-analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of non-resectable liver metastases from colorectal cancer. J Natl Cancer Inst 1996;88:252-8.
15. Schlag P, Hohenberger P, Hölting T, Buhl K, Schwarz V, Herfarth C. Hepatic arterial infusion (HAI) chemotherapy for liver metastases of colorectal cancer using 5-FU. Eur J Surg Oncol 1990;16:99-104.
16. Metzger U, Weder W, Röthlin M, Largiader F. Phase II study of intra-arterial Fluorouracil and mitomycin C for liver metastases of colorectal cancer. Recent Results Cancer Res 1991;121:198-204.
17. Sugihara K. Continuous hepatic arterial infusion of 5-fluorouracil for unresectable colorectal liver metastases: phase II study. Surgery 1995;117:624-8.
18. Howell JD, McArdle CS, Kerr DJ, Buckles J, Ledermann JA, Taylor I, et al. A phase II study of regional 2-weekly 5-fluorouracil infusion with intravenous folinic acid in the treatment of colorectal liver metastases. Br J Cancer 1997;76:1390-3.
19. Cohen A, Kaufman S, Wood W, Greenfield A. Regional hepatic chemotherapy using an implantable drug infusion pump. Am J Surg 1983;145:529-33.
20. Niederhuber J, Ensminger W, Gyves J, Thrall J, Walker S, Cozzi E. Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer 1984;53:1336-43.
21. Hohn D, Rayner S, Economou J, Ignoffo R, Lewis B, Stagg R. Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion. Cancer 1986;57:465-70.
22. Martin J, O'Connell M, Wieand H, Fitzgibbons R, Mailliard J, Rubin J, et al. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. Arch Surg 1990;125:1022-7.
23. Rougier P, Laplanche A, Huguier M, Hay J, Ollivier J, Escat J, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 1992;10:1112-8.
24. Allen-Mersh T, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994;344:1255-60.
25. Kemeny N, Seiter K, Conti J, Cohen A, Bertino J, Sigurdson E, et al. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. Cancer 1994;73:1134-42.
26. Yoshikawa M, Ebara M, Nakano T, Minoyama A, Sugiura N, Ohto M. Percutaneous transaxillary catheter insertion for hepatic artery infusion chemotherapy. AJR Am J Roentgenol 1992;158:885-6.
27. Sawada S, Fujiwara Y, Koyama T, Katsube Y, Kato T, Oshima T, et al. Percutaneous transfemoral arterial infusion chemotherapy for metastatic liver tumors - placement of 3 Fr balloon catheters. Radiat Med 1992;10:6-12.
28. Germer C, Boese-Landgraf J, Albrecht D, Wagner A, Wolf K, Buhr H. The fully implantable minimally invasive hepatic artery catheter for locoregional chemotherapy of nonresectable liver metastases in defective conventional therapy catheters. Chirurg 1996;67:458-62.
29. Oi H, Kishimoto H, Matsushita M, Hori M, Nakamura H. Percutaneous implantation of hepatic artery infusion reservoir by sonographically guided left subclavian artery puncture. AJR Am J Roentgenol 1996;166:821-2.
30. Hayashi N, Sakai T, Kitagawa M, Kimoto T, Ishii Y. Percutaneous long-term arterial access with implantable ports. Direct subclavian approach with US. Eur J Radiol 1998;26:304-8.
31. Seki H, Kimura M, Yoshimura N, Yamamoto S, Ozaki T, Sakai K. Hepatic arterial infusion chemotherapy using percutaneous catheter placement with an implantable port: assessment of factors affecting patency of the hepatic artery. Clin Radiol 1999;54:221-7.
32. Wacker F, Boese-Landgraf J, Wagner A, Albrecht D, Wolf K, Fobbe F. Minimally invasive catheter implantation for regional chemotherapy of the liver: a new percutaneous transsubclavian approach. Cardiovasc Intervent Radiol 1997;20:128-32.
33. Mosseri M, Fingert HJ, Varticousky L, Chokshi S, Isner JM. In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase-C mediated vasoconstriction of vascular smooth muscle. Cancer Res 1993;53:3028-33.
34. Roth J, Wallner B, Safi F. Arterial perfusion abnormalities of the liver after hepatic arterial infusion chemotherapy and their correlation with changes in the metastases: evaluation with CT and angiography. AJR Am J Roentgenol 1989;153:751-4.
35. Kemeny N, Seiter K, Niedzwiecki D, Chapman D, Sigurdson E, Cohen A, et al. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamthasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer 1992;69:327-34.
36. Monreal M, Alastrue A, Rull M, Mira X, Muxart J, Rosell R, et al. Upper extremity deep venous thrombosis in cancer patients with venous access device - prophylaxis with a low molecular weight heparin (Fragmin): Thromb Haemost 1996;75:251-3.
37. Levine MN. Prevention of thrombotic disorders in cancer patients undergoing chemotherapy. Thromb Haemost 1997;78:133-6.